Literature DB >> 12097806

A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association.

Anna Leszczyńska-Rodziewicz1, Piotr M Czerski, Paweł Kapelski, Sebastian Godlewski, Monika Dmitrzak-Weglarz, Janusz Rybakowski, Joanna Hauser.   

Abstract

Norepinephrine is one of the neurotransmitters which has been implicated in the pathogenesis of mood disorders and schizophrenia. The norepinephrine transporter (NET) gene may be a candidate gene for the study of the genetics of these disorders. In this study, 198 patients with schizophrenia and 100 patients with bipolar disorder were analysed for a silent mutation 1287 A/G, located in the coding region (exon 9) of the NET gene, to determine the association between this polymorphism of the NET gene and bipolar disorder or schizophrenia. No association was found between the studied polymorphism of the NET gene and either bipolar disorder or schizophrenia. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097806     DOI: 10.1159/000063668

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  8 in total

Review 1.  Cross-species assessments of motor and exploratory behavior related to bipolar disorder.

Authors:  Brook L Henry; Arpi Minassian; Jared W Young; Martin P Paulus; Mark A Geyer; William Perry
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

Review 2.  Genetic polymorphisms in the expression and treatment of neuropsychiatric disorders.

Authors:  Thomas W McAllister; Lanier Summerall
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

Review 3.  From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.

Authors:  Alessandro Serretti; Paola Artioli
Journal:  Psychopharmacology (Berl)       Date:  2004-03-02       Impact factor: 4.530

4.  Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations.

Authors:  Inna Belfer; Gabriel Phillips; Julie Taubman; Heather Hipp; Robert H Lipsky; Mary-Anne Enoch; Mitchell B Max; David Goldman
Journal:  J Hum Genet       Date:  2004       Impact factor: 3.172

5.  Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression.

Authors:  M K Hahn; J U Blackford; K Haman; M Mazei-Robison; B A English; H C Prasad; A Steele; L Hazelwood; H M Fentress; R Myers; R D Blakely; E Sanders-Bush; R Shelton
Journal:  Genes Brain Behav       Date:  2007-12-06       Impact factor: 3.449

6.  Pharmacogenetics of antidepressants.

Authors:  Concetta Crisafulli; Chiara Fabbri; Stefano Porcelli; Antonio Drago; Edoardo Spina; Diana De Ronchi; Alessandro Serretti
Journal:  Front Pharmacol       Date:  2011-02-16       Impact factor: 5.810

7.  A Genetic Susceptibility Mechanism for Major Depression: Combinations of polymorphisms Defined the Risk of Major Depression and Subpopulations.

Authors:  Yanfang Wang; Ning Sun; Suping Li; Qiaorong Du; Yong Xu; Zhifeng Liu; Kerang Zhang
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

8.  Association Study between Norepinephrine Transporter Gene Polymorphism and Schizophrenia in a Korean Population.

Authors:  Mira Choo; Jung-A Hwang; Sang Won Jeon; So-Young Oh; Ho-Kyoung Yoon; Heon-Jeong Lee; Yong-Ku Kim
Journal:  Psychiatry Investig       Date:  2015-09-30       Impact factor: 2.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.